English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Dec 28, 2025

Voyager lays off staff following discontinuation of two programs by partner Novartis

+ Pharmaceuticals
Patient Daily | Dec 28, 2025

FDA may grant fast-track review vouchers to two Merck experimental drugs

+ Pharmaceuticals
Patient Daily | Dec 28, 2025

Four key questions pharma executives must ask before signing employment contracts

+ Pharmaceuticals
Patient Daily | Dec 28, 2025

Researchers find lung immune cells drive allergy-related inflammation

+ Pharmaceuticals
Patient Daily | Dec 28, 2025

AI-assisted tool helps reduce wait times for autism diagnosis in Missouri

+ Pharmaceuticals
Patient Daily | Dec 28, 2025

Hybrid health model shows promise for rural Ontario’s primary care access

+ Pharmaceuticals
Patient Daily | Dec 28, 2025

Researchers find potential for new antibiotics from ant species

+ Pharmaceuticals
Patient Daily | Dec 28, 2025

Study finds clearer guidance needed for parents on early peanut introduction

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily